LCN2 and triple-A syndrome: In a mouse model of AAA, Tarín et al. showed that genetic deletion of Lcn2 or neutralization of NGAL with polyclonal anti-NGAL antibody injections protected against AAA-induced lesions, with lower neutrophil infiltration and the diminution of MMP activity30.